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Shiga-like toxins (Stx) represent a group of bacterial toxins involved in human and animal
diseases. Stx is produced by enterohemorrhagic Escherichia coli, Shigella dysenteriae
type 1, Citrobacter freundii, and Aeromonas spp.; Stx is an important cause of bloody
diarrhea and hemolytic uremic syndrome (HUS). The aim of this study was to identify the
stx1/stx2 genes in clinical strains and outer membrane vesicles (OMVs) of Aeromonas
spp., 66 strains were isolated from children who live in Mexico City, and Stx effects
were evaluated in Vero cell cultures. The capacity to express active Stx1 and Stx2
toxins was determined in Vero cell cultures and the concentration of Stx was evaluated
by 50% lethal dose (LD50) assays, observing inhibition of damaged cells by specific
monoclonal antibodies. The results obtained in this study support the hypothesis that
the stx gene is another putative virulence factor of Aeromonas, and since this gene can
be transferred horizontally through OMVs this genus should be included as a possible
causal agents of gastroenteritis and it should be reported as part of standard health
surveillance procedures. Furthermore, these results indicate that the Aeromonas genus
might be a potential causative agent of HUS.
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INTRODUCTION
For several years, the significance of Aeromonas spp., as a human diarrhea-causing agent was
controversial; several studies demonstrated that the pathogenic mechanism of Aeromonas is
multifactorial because many virulence factors are involved, including the production of cytotoxins
(Castro-Escarpulli et al., 2002, 2003). These toxins can cause diarrhea or hemorrhagic colitis,
and may play a major role in the hemolytic-uremic syndrome (HUS) and TTP development
(Bogdanovic´ et al., 1991; Fang et al., 1999; Monforte-Cirac et al., 2010).
Abbreviations: Ab, Antibody; HUS, Hemolytic uremic syndrome; INP, Instituto Nacional de Pediatria Mexico; LD50,
Median lethal dose; OMVs, Outer membrane vesicles; PCR, Polymerase chain reaction; STEC, Shiga toxin-producing E.
coli; Stx, Shiga-like toxin; TTP, Thrombotic thrombocytopenic purpura.
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The cytotoxins implicated in these diseases include Shiga
toxin and the closely related Stx. Stx variants are expressed in
Shigella, Enterobacter, Citrobacter, Acinetobacter, Campylobacter,
and Hamiltonella bacterial species (Mauro and Koudelka, 2011).
Alperi and Figueras (2010) described the presence of Stx1 and
Stx2 in clinical isolates of Aeromonas spp., associated with
gastroenteritis, hemorrhagic colitis, and HUS. Genes encoding
these toxins are located in different lambdoid bacteriophages that
lysogenize this strain. In addition, the genus Aeromonas has a
zero-secretion system named OMVs. OMVs could be a means by
which some proteins, RNA, periplasmic space components and
other components associated with virulence, may be transferred
horizontally to other genera; therefore, it is believed that OMVs
play an important role in pathogenicity (Guerrero-Mandujano
et al., 2015a,b).
For this reason, the aim of this study was to evaluate the
damage caused by the production of Stx by strains isolated from
Mexico City children in Vero cell cultures.
MATERIALS AND METHODS
Strains
This study included 66 clinical isolates from the INP, 54 obtained
from intestinal and 12 from extra-intestinal infections. Strains
were isolated from specimens obtained for routine testing at
the mentioned hospital; therefore, no informed consent was
required from parents or legal guardians of children. All strains
were genetically identified by 16S rDNA-RFLP (Hernández-
Cortez et al., 2011). The typed strain for Escherichia coli
O157:H7 CECT 4076 was used as the positive control and
E. coli K12 strain (5512 ENCB) from the collection of the
Medical Bacteriology Laboratory (Escuela Nacional de Ciencias
Biologicas, IPN) was used as the negative control for toxin
production. The strains were maintained for short periods at
room temperature on blood agar based slants; for longer storage,
they were either frozen at −70◦C in 20% (w/v) glycerol-Todd-
Hewitt broth (Oxoid, Mexico) or lyophilized in 7.5% horse
glucose serum.
DNA Extraction
All the cultures were grown on tryptic soy agar at 30◦C
for 18 h. The genomic DNA of each strain was obtained
through InstaGene Matrix (BioRad R©, Mexico) according to the
instructions provided by the manufacturer. DNA purity and
quantity were determined by using the Ampli Quant AQ-07
spectrophotometer. DNA was stored at−20◦C until use.
stx1 and stx2 PCR Amplifications
The presence of stx1 and stx2 from DNA of OMVs and genomic
DNA was detected by single PCR reactions using primers
STX1F/STX1R and STXF/STXR with a 144 and 217 bp product,
respectively, these primers were designed based on the sequence
of subunit A. The primers, the reaction, and amplification
conditions were processed as previously described by Hernández-
Cortez et al. (2013), with the positive (E. coli O157:H7) and
negative (E. coli K12) controls.
DNA Sequencing
Polymerase chain reaction products were purified using a
PureLink Quick Gel Extraction Kit (Invitrogen R©, Mexico)
according to manufacturer’s instructions. The products were
directly sequenced on an ABI-PRISM 310 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA) using the forward
and reverse primers used for PCR, according to manufacturer’s
instructions. Sequencing was performed at the Instituto de
Biología, UNAM (Mexico). Sequence analysis was performed
with the Basic Local Alignment Search Tool (BLAST) provided
by the National Center for Biotechnology Information (NCBI).
Microplate Vero Cells Preparations
This procedure was performed in 96-well microplates with
Vero (ATCC CCL81) cell monolayer with 80% confluence,
adding minimal essential medium (MEM; Invitro R©, Mexico)
supplemented with 10% v/v fetal bovine serum (FBS; Invitro R©,
Mexico).
The cell suspension was homogenized and adjusted to 105–
106 cells/mL using a Neubauer chamber. After adjusting, the
suspension was deposited in 200-µL well. The microplates were
incubated at 37◦C under 5% CO2 for 24 h (CO2 Incubator, VWR
Scientific, USA) (Giono-Cerezo et al., 1994).
Cell-Free Bacterial Preparations
Five colonies from each blood agar plate were inoculated into
3 mL of Craig medium (0.4% yeast extract, 3% casamino acids,
0.05% K2HPO4). These were incubated for 24 h at 37◦C and
the optical density of the bacterial culture used was 0.25 at
600 nm. Cell-free preparations were made by centrifuging the
cultures at 14,000 g for 10 min at 4◦C, followed by filtration of
the supernatant through a membrane filter (pore size 0.45 pm,
Sartorius Minisart NML). Cell-free supernatants were stored
at −20◦C. A total of 66 cell-free bacterial preparations were
obtained in this way; the positive control (E. coli O157:H7) and
the negative control (E. coli K12) were obtained also in the same
way (Giono-Cerezo et al., 1994).
Cytotoxic Assay and LD50 Determination
The cell-free filtrate (20 µL) was inoculated into wells containing
cells and the respective growth medium without antibiotics.
Inoculated cells were incubated for 96 h at 37◦C with 5%
CO2 and observed every 24 h on the inverted microscope.
The cytotoxic effect was expected to appear as rounding and
shrinkage of cells with thick granulation and, finally, progressive
and irreversible destruction of the monolayer. All tests were
performed in duplicate; viability controls with MEM and Craig
medium were performed also (Giono-Cerezo et al., 1994).
The LD50 was determined in Aeromonas strains detected as
positive for causing cytotoxic damage in Vero cells. A standard
96-well microplate with Vero cells was prepared as indicated in
2.6, but the medium was changed to 100 µL of MEM with 1%
BFS. This preparation was exposed to 100µL of cell -free bacterial
preparation, and serial dilutions were done on the whole row
of plates. After 24 h of incubation at 37◦C with 5% CO2, the
LD50 was determined, under the inverted microscope. LD50 was
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assigned to the well in which 50% of Vero cells were damaged and
50% un-damaged (Marques et al., 1986).
Blockade and Toxin Neutralization Assay
The toxin neutralization assay was performed in the strains that
induced cytotoxic damage in Vero cells because this damage is
indicative of Stx. For this test, a microplate was prepared with
Vero cell grown to a confluence of 90–100% with the LD50 of each
cell-free bacterial preparation. To perform the neutralization
assay to show cell damage produced as a consequence of
Stx action, two monoclonal antibodies (Universidad Nacional
Autónoma de México) obtained from E. coli O157:H7 were
used.
For each Ab a Bradford protein quantitation was done
according to manufacturer’s instructions (Biorad), with a result of
78.2 and 74.8 µg/µL, respectively, of anti-Stx1 and anti-Stx2 A.
The concentrated Ab was worked and a double dilution of
the Ab. Then, 10 µL of the Ab (anti-STX1 or anti-STX2)
was incubated with 190 µL of the cell-free supernatant at a
concentration of LD50 for 1 h at 37◦C. Following this, 200 µL
of the latter was inoculated into Vero cells at 90% of confluence
and incubated for 24 h at 37◦C with 5% CO2 (Marques et al.,
1986).
OMVs Procurement and DNA Extraction
from OMVs
Outer membrane vesicles were obtained from Aeromonas
hydrophila F-0050. The protocol was performed as previously
described by Guerrero-Mandujano et al. (2015a).
The OMVs’ DNA was obtained through InstaGene Matrix
(BioRad R©, Mexico) according to the instructions provided by the
manufacturer. Then, the OMVs’ DNA was purified with the DNA
extraction phenol-chloroform technique (Guerrero-Mandujano
et al., 2015b).
FIGURE 1 | Cytotoxicity assay and LD50 determination performed in Vero cell cultures. (A) Vero cell culture with Minimal Essential Medium (Viability test).
(B) Vero cell culture with Craig Medium (Viability test). (C) Negative control with E. coli K12. (D) Positive control with E. coli O157: H7, Cytotoxic damage is shown
(arrows) by destruction of the cell monolayer and “old lace” effect. (E) Cytotoxic damage of A. hydrophila F-0050 strain. (F) Cytotoxic damage of A. caviae 421423
strain. (G) Graphical representation of the LD50 titer of all strains.
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RESULTS
stx1 and stx2 Gene PCR Amplifications
Polymerase chain reaction screening of 66 clinical Aeromonas
strains showed that 22/66 (33.3%) strains contained the stx1 gene,
42/66 (63.6%) strains contained both genes, no strains contained
only the stx2 gene, and 2/66 (3%) strains were negative for both
genes.
DNA Sequencing
BLASTn analysis showed a 79 to 99% similarity and an expected
value of 3e−16/2e−97 between the stx-1/stx-2 genes of E. coli
O157:H7 and the amplicon from Aeromonas spp., strains.
Cytotoxic Assay and LD50 Determination
The cytotoxicity test performed in Vero cell cultures showed that
17/66 (25.7%) cell-free bacterial preparations caused cytotoxic
FIGURE 2 | Inhibition of cytotoxic effect induced in Vero cells culture by cell-free bacterial preparations of Aeromonas spp. strains bearing the stx1
or stx2 gene.
Frontiers in Microbiology | www.frontiersin.org 4 September 2016 | Volume 7 | Article 1522
fmicb-07-01522 September 26, 2016 Time: 10:48 # 5
Palma-Martínez et al. Aeromonas Shiga-Like Toxin
damage, suggesting production of an active Stx (Figure 1),
revealed by the characteristic damage caused by Stx.
The results for determining the LD50 titer were as follows:
6/17 (35.2%) cell-free bacterial preparations presented a titer of
1:16; 5/17 (29.4%) cell-free bacterial preparations depicted a titer
of 1:8; 3/17 (17.6%) cell-free bacterial preparations had a titer of
1:64; 2/17 (11.7%) cell-free bacterial preparations with a titer of
1:32; and 1/17 (5.8%) cell-free bacterial preparations with a titer
of 1:256 (Figure 1G).
Toxin Neutralization
The application of anti-STX1 Ab in 11/17 (64.7%) strains the
damage to cells in the supernatant was completely inhibited
at 39.1 µg/µL Ab concentration; in 4/17 (23.5%) cell-free
bacterial preparations, reduced cell damage was observed
at the same concentration; and in 2/17 (11.7%) cell-free
bacterial preparations, cell damage was completely inhibited at
a concentration 78.2 µg/µL. Using the Ab anti-STX2 showed
that in 9/17 (52.9%) cell-free bacterial preparations, cell damage
was totally inhibited at 37.4 µg/µL, and 6/17 (35.2%) cell-
free bacterial preparations showed reduced cell damage at the
same concentration; and in 2/17 (11.7%) cell-free bacterial
preparations, cell damage was completely inhibited with an Ab
concentration of 74.8 µg/µL (Figures 2 and 3).
stx1 Gene PCR Amplifications from
OMVs
Polymerase chain reaction of OMVs’ DNA of A. hydrophila F-
0050 revealed the OMVs contained the gen stx1; hence, OMVs
might be a potential vehicle for horizontal virulence genes
transfer (Figure 4).
DISCUSSION
The genus Aeromonas, as a producer of Stx, could be an emergent
pathogen that causes diarrhea mainly in pediatric patients
(Hernández-Cortez et al., 2011; Figueras and Baez-Hidalgo,
2014). Nevertheless, this genus has become more relevant in the
medical area, as it is a pathogen causing HUS (San Joaquín and
Pickett, 1988; Bogdanovic´ et al., 1991; Robson et al., 1992; Fang
et al., 1999; Monforte-Cirac et al., 2010).
In this study, we found, by PCR amplification of the stx1 and
stx2 genes, that 22/66 (33.3%) of the aeromonad strains contained
the stx1 gene, 42/66 (63.6%) strains contained both genes, and
there were no strains containing stx2 alone. This can lead us
to suggest that this gene is widely distributed in the Aeromonas
strains isolated from pediatric patients and that these patients can
be at risk for developing HUS.
There is only one previous report in which the stx genes were
studied in Aeromonas strains isolated from different hospitals
in Spain; the results obtained were that 19/80 (23.7%) strains
had the stx1 gene and only 1/80 (1.25%) strain was positive for
both genes (Alperi and Figueras, 2010). These results convey
that there is a greater distribution of the gene in Mexican
strains; however, we should take into account that, in Spain,
the Aeromonas genus is a known gastrointestinal pathogen
FIGURE 3 | Percentage of strains that showed inhibition or reduction
of cell damage. (A) Neutralization with the anti-Stx1 Ab. (B) Neutralization
with the anti-Stx2 Ab.
FIGURE 4 | Electropherogram of stx1 gene amplification from OMVs’
DNA. (1) Kapa Universal Ladder, (2) Negative control, (3) OMVs of
A. hydrophila F-0050, (4) A. hydrophila F-0050, (5) OMVs of E. coli O157:H7,
and (6) E. coli O157:H7.
isolated routinely in patients with a gastrointestinal profile,
therefore, an adequate treatment is given to confront this
genus.
In Mexico, this genus is not included in the list of pathogens
causing diarrhea and it is not isolated routinely; as a result, it is
difficult to give any treatment and good quality of life to patients;
moreover, there are no statistics about its prevalence. In addition,
the genus becomes more relevant due to the socioeconomic
conditions of the Mexican population, which include water
shortage; this facilitates its transmission and increases the
possibility of HUS becoming a public health problem.
Sequencing of the amplicons was carried out and a Blast
search was performed, which showed 79–99% similarity and an
expectancy value of 3e−16/2e−97 between genes stx1/stx2 as
compared to E. coli O157:H7.
The LD50 was determined to evaluate the cytotoxic damage in
Vero cell culture; with this parameter and based on Marques et al.
(1986), the strains can be grouped in low (2 × 101 to 6 × 102),
moderate (103–104), and high (105–108) production (Figure 1G).
Marques et al. (1986) carried out a study in which they made a
similar assay to that of the present study, but with different strains
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of STEC, they obtained that 262/400 (63%) strains were grouped
as low Stx producers, and 48% produced cytotoxic damage;
nevertheless, in 40% of these strains the cytotoxic damage was
inhibited with anti-Stx antibodies.
In the present study, 25.7% of bacteria-free preparations
caused cytotoxic damage characteristic of Stx in Vero cells,
suggesting production of active Stx, all Aeromonas strains were
grouped as low producers of Stx; however, in 50–70% of the
cell-free supernatants, the cellular damage was inhibited, and
in 20–30% of cell-free supernatants the cellular damage was
reduced (Figure 3). The cell-free supernatants in which cellular
damage was reduced this could have been because of two
variants in the toxin present in the supernatant, consequently, as
they are different immunologically, the Stx could not be totally
inhibited and the cellular damage remained (Marques et al.,
1986).
Two previous studies (Haque et al., 1996; Alperi and Figueras,
2010) obtained 10.2% and 10.53% of Stx1-producing Aeromonas
strains, respectively. The reason for a higher percentage of
Aeromonas strains producing active Stx could be due to the
high availability of the Stx bacteriophage inside the culture
as some STEC strains carriers of the Stx bacteriophage have
been isolated from urban wastewater from treatment plants,
wastewater from slaughterhouses and cattle stools (García-
Aljaro et al., 2004, 2009). Similarly transduction studies have
been carried out in vivo with Stx phages from E. coli, which
can infect intestinal microbiota bacteria, giving the toxigenic
characteristic to strains that were not infected before (Acheson
et al., 1998; Schmidt et al., 1999; Gamage et al., 2003). The
same could happen with the genus Aeromonas when inducing
a gastrointestinal profile, followed by the fact that the genus
Aeromonas has the ability to capture and integrate virulence
factors in its genome, and one of these is the Stx-encoding
gene.
The rest of the strains caused cytotonic damage in the cell,
possibly suggesting production of different toxins other than
Stx, since Aeromonas is a genus capable of producing two
cytotonic enterotoxins, thermostable (AST) and thermolabile
(ALT) (Figueras and Baez-Hidalgo, 2014), that can cause
cytotonic damage in Vero cells; another possibility is that the
Aeromonas strains have more than one bacteriophage inserted in
their genome, as it has been demonstrated that STEC strains with
double lysogeny are able to regulate bacteriophages to inhibit the
capacity of lytic cycle induction, which results in a decrease of
Stx production but without losing the gene (García-Aljaro et al.,
2004; Imamovic and Muniesa, 2011). Therefore, it is necessary
to establish how many bacteriophages do Aeromonas strains
contain, including in the present study, to be able to correlate
the presence of Stx bacteriophages and the amount produced
of Stx.
On the other hand, the presence of Stx bacteriophages in
inducible Aeromonas represents a horizontal transfer mechanism
of the stx gene, but it is not the only one. In more recent
studies, it has been determined that Aeromonas are capable of
producing OMVs (Guerrero-Mandujano et al., 2015a) and these
OMVs are capable of transporting integrated DNA (Guerrero-
Mandujano et al., 2015b). In the present study, we amplified
the stx1 gene from the DNA extracted from the OMVs of one
A. hydrophila strain of clinical origin, which induced cytotoxic
damage in Vero cells, and this damage was inhibited with
anti-Stx antibodies. This indicates that the Stx bacteriophage
is the transport mechanism of the stx gene; furthermore, the
OMVs and the recently called Transport System Type 0 are
capable of spreading the stx gene interspecies or intraspecies.
Nevertheless, it is required to confirm if the gene contained in
the OMVs is complete. The results obtained in this study support
the hypothesis that the stx gene is another putative virulence
factor of Aeromonas that might be transferred through OMVs.
It could represent another mechanism for horizontal transport
of the stx gene to other Aeromonas strains and/or other bacterial
genera.
For this reason, this genus should be included as possible
causative agent of gastroenteritis when trying to identify causal
agents and should be reported as part of standard health
surveillance procedures.
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